What caused the pre-market spike in TMD.TO stock?

The jump reflects heavy trading and low prior prices, with **117,220** shares traded pre-market versus a **45,936** average. No formal press release was posted; monitor official filings for company updates and regulatory news.

What is Meyka AI's view and grade for TMD.TO stock?

Meyka AI rates TMD.TO **68.68 / 100 (Grade B, HOLD)**. The grade factors S&P 500 and sector comparison, growth, key metrics and analyst consensus. This is informational and not investment advice.

What is the 12‑month forecast for TMD.TO stock?

Meyka AI's forecast model projects a **C$1.75** 12‑month target, implying **+55.56%** from the current **C$1.125** reference. Forecasts are model-based projections and not guarantees.

How risky is trading TMD.TO stock right now?

High risk due to severe intraday volatility (range **C$0.05–C$1.13**) and a small market cap **C$128.30M**. Expect wide spreads, rapid swings and sensitivity to news or retail flows.

CA Stocks

TMD.TO Titan Medical (TSX) at C$1.13 pre-market on 117,220 vol: check catalysts 16 Mar 2026

ByHuzaifa Zahoor March 16, 2026

TMD.TO stock is trading at C$1.13 in the pre-market on heavy activity after an open at C$0.05 and a previous close of C$0.05. Volume hit 117,220 shares versus an average volume of 45,936, making this a clear high-volume mover on the TSX in Canada. The intraday range is C$0.05–C$1.13, and market cap stands at C$128,295,000. We use Meyka AI’s real-time signals to connect the volume spike to liquidity, valuation and short-term catalysts for traders and longer-term investors.